James P. Gilligan serves as Executive at UNIGENE LABORATORIES INC, where they oversee executive responsibilities. Since joining the company, James P. Gilligan has executed 10 insider transactions totaling $178.5K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 15, 2010 involved receiving (via award) 3,000 shares valued at $0.
James P. Gilligan currently holds 121,895 shares of UNIGENE LABORATORIES INC (UGNE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James P. Gilligan has been a net seller of UGNE stock. They have purchased $1.4K and sold $177.1K worth of shares.
James P. Gilligan's most recent insider trade was on Jan 15, 2010, when they sold 3,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $1.15 |
| Discretionary |
| Nov 3, 2009 | UGNE | $72.5K | Option Exercise | 115,000 | $0.63 | Discretionary |
| Nov 3, 2009 | UGNE | $12.3K | Sale | 10,000 | $1.23 | Discretionary |
| Oct 6, 2008 | HBRM | $0 | Purchase | 605,769 | $N/A | Discretionary |
| Apr 17, 2008 | UGNE | $0 | Award | 14,035 | $N/A | Discretionary |
| May 25, 2007 | UGNE | $0 | Gift | 500 | $N/A | Discretionary |
| May 23, 2007 | UGNE | $1.4K | Purchase | 600 | $2.40 | Discretionary |
| Dec 21, 2005 | UGNE | $39.4K | Option Exercise | 20,000 | $1.97 | Discretionary |
| Dec 21, 2005 | UGNE | $90.0K | Sale | 20,000 | $4.50 | Discretionary |